The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer
| Image |  |
|---|---|
| Description | scientific article published on 01 March 2005 |
| Author/s |
author: Aled Clayton Zsuzsanna Tabi |
| Publication date | March 1, 2005 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |